chartexchange

Protara Therapeutics Announces Third Quarter 2026 Financial Results and Provides a Business Update

GlobeNewswire Inc. | Nov 6, 2026 8:00 AM EST

Expect to complete enrollment of the BCG-Unresponsive registrational cohort of the ADVANCED-2 trial of TARA-002 in NMIBC by year-end 2026

Read original article